For January 2021, there are a number of changes to our formulary and Utilization Management (UM) to achieve better affordability and improved pharmacy plan performance for clients.
At Cigna, our utilization management (UM) solutions work to manage benefit plan expenses by defending against potentially harmful, ineffective or unnecessary drug treatments.
Beginning in August 2020, customers who fill prescriptions through Express Scripts Pharmacy®, Cigna's home delivery pharmacy, will now see a vibrant new look with a new logo and branding refresh.
While many stand-alone PBMs focus on the unit cost of the drug, Cigna integrates medical, pharmacy, and behavioral benefits to drive to the lowest total health care cost, while providing whole-person support for customers.
The United States Food and Drug Administration (FDA) recently approved three new drugs (Nurtec™ ODT, Reyvow™, and Ubrelvy™) for the acute treatment of migraine headaches and one new drug for the prevention of migraine headaches (Vyepti™).
For the fourth year in a row, Cigna's Value of Integration study demonstrates that connecting medical, pharmacy and behavioral benefits increases customer engagement, supports the whole person and reduces total medical costs.
As of May 1, 2020, Express Scripts®, a Cigna company, began offering Parachute RxSM. This temporary new drug savings program helps ensure that Americans who are uninsured continue to stay adherent to their prescription medications during the COVID-19 pandemic.
Behavioral and mental health challenges have a significant impact on society. This is why we’re proud to introduce inMynd – a new behavioral health solution included with our integrated pharmacy benefits at no additional cost.
Our top priority is to protect the health and well-being of our clients, customers and our employees and their families. We have put together resources, information, and helpful links on Cigna.com to keep you up-to-date and informed.
As part of our ongoing commitment to provide affordable and quality health care coverage, we regularly review and update our formularies. We act on research findings gleaned from integrated benefits and new drugs to market, such as biosimilars and other opportunities to reduce drug spend and improve health.
Approximately one year has passed since Cigna and Express Scripts began working together as a combined organization. A significant milestone in our combination with Express Scripts is an upgrade to our pharmacy claim-processing platform – moving to our proprietary Express Scripts claim engine.
Effective in 2020, upon a client’s next renewal, coverage of vaccines will be available under the pharmacy benefit. Previously, vaccines were typically available only through the medical benefit. Now, customers can simply visit an in-network pharmacy, show their prescription ID card, and request a flu shot or other covered vaccine.
SafeGuardRx for Cigna is a program that helps limit our clients’ financial exposure, driving down costs for certain complex, costly conditions. These include oncology, inflammatory conditions, multiple sclerosis and other rare conditions.
A first-of-its-kind treatment for patients with peanut allergy is now available. The U.S. Food and Drug Administration (FDA) announced approval of Palforzia®, by the manufacturer Aimmune Therapeutics, Inc., as of January 31, 2020.
The issues of opioid misuse and overdose don’t stop, so we won’t stop either. A new outreach effort works to identify and reach out to opioid users with a recently detected medical emergency. Our goal is to help lead them to beneficial resources that might reduce their risk for overdose.
As a Pharmacy Benefits Manager within a global health service company, we uniquely deliver personalized solutions that support the whole person. Through integrated capabilities, we address every aspect of our customers’ wellness, including physical and emotional health. Our goal is to deliver greater value to you and your employees, helping them improve their well-being while you control your costs.
Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names
Health benefit plans vary, but in general to be eligible for coverage a drug must be approved by the Food and Drug Administration (FDA), prescribed by a health care professional, purchased from a licensed pharmacy and medically necessary. Some plans require use an in-network pharmacy for prescriptions to be covered. Coverage is subject to any plan deductible, copayment and/or coinsurance requirements. Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and complete details of prescription drug coverage, contact a Cigna representative.
All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Cigna Behavioral Health, Inc., Cigna Health Management, Inc., Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.
© 2020 Cigna. All rights reserved